Trial NCT02658812

View at ClinicalTrials.gov 
Org. Study IDs: 2014-0034
Secondary IDs: 2014-0034 NCI-2016-00199 P30CA016672

Last trial update was posted on 2023-01-25

MeSH Interventions

Talimogene laherparepvec

MeSH Conditions

Breast Neoplasms Carcinoma Inflammatory Breast Neoplasms Recurrence

Other Conditions

Malignant Chest Wall Neoplasm Recurrent Breast Carcinoma Recurrent Inflammatory Breast Carcinoma Stage IV Breast Cancer AJCC v6 and v7 Stage IV Inflammatory Breast Carcinoma

Stopping Reasons

Per PI

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID